Original articles \ Review Articles
Medical device research update after the adoption of the EU legislation (MDR)
aServicio de Cardiología, Hospital Universitario La Paz, Madrid, Spain
bFundación Epic, León, Spain
cAgencia Española de Medicamentos y Productos Sanitarios (AEMPS), Madrid, Spain
dCentro Nacional de Certificación de Productos Sanitarios, Madrid, Spain
eAsociación Nacional de Comités de Ética (ANCEI), Madrid, Spain
fFederación Española de Empresas de Tecnología Sanitaria (FENIN), Madrid, Spain
giVascular, Barcelona, Spain
hAortyx, Barcelona, Spain
ipInvestiga, Pontevedra, Spain
jMadrija Consultoría, Toledo, Spain
kStart Up SL, Oviedo, Asturias, Spain
lIE University, Programa Dirección e Innovación en el Sector Salud, Madrid, Spain
mSoinde Neuro SL, Madrid, Spain
REC Interv Cardiol. 2025;7:255-263
The role of implant projection in optimizing transcatheter aortic valve implantation
aÁrea del Corazón, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
bInstituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Asturias, Spain
cFacultad de Medicina, Universidad de Oviedo, Oviedo, Asturias, Spain
◊Both authors shared equal contribution for the first authorship.
REC Interv Cardiol. 2024;6:332-339
Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry
aInstituto Cardiovascular, Hospital Clínico San Carlos, Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (IdISSC), Madrid, Spain
bFacultad de Medicina, Universidad Complutense de Madrid, Madrid, Spain
REC Interv Cardiol. 2024;6:321-331
Functional assessment of coronary stenosis: alternative hyperemic, nonhyperemic, and angiographic indexes
aDepartment of Interventional Cardiology, Ospedale Generale Provinciale - Macerata, Italy
bDepartment of Cardiology, Ospedale Generale Provinciale - Macerata, Italy
REC Interv Cardiol. 2024;6:224-234
Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory
aCardialysis, Rotterdam, The Netherlands
bEuropean Cardiovascular Research Institute, Rotterdam, The Netherlands
cCardiology Department, Hospital Universitario Marqués de Valdecilla, Instituto de Investigación Valdecilla (IDIVAL), Santander, Cantabria, Spain
dCardiology Department, Landspitali University Hospital, Reykjavik, Iceland
eFaculty of Medicine, University of Iceland, Reykjavik, Iceland
fCardiology Department, Cork University Hospital, Cork, Ireland
gDepartment of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
hCardiology Department, University of Louvain Medical School, Brussels, Belgium
iDepartment of Cardiology, Erasmus MC Cardiovascular Institute, Thorax Center, Rotterdam, The Netherlands
jCardiology Department, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
kCardiology Department, Lund University, Skane University Hospital, Lund, Sweden
lCardiology Department, Hospital Universitario de Leon, Leon, Spain
mCardiology Department, Leiden University Medical Center, Leiden, The Netherlands
REC Interv Cardiol. 2024;6:213-223
Atrial functional mitral regurgitation: was this new entity needed?
aDepartment of Cardiac Surgery, University Medical Centre Maribor, Maribor, Slovenia
bCardiovascular Institute, Azienda Ospedaliero Universitaria di Ferrara, Ferrara, Italy
cCardiology Section, Department of Medicine, University of Verona, Italy
dHeart Institute, University Hospital Germans Trias i Pujol, Badalona, Barcelona, Spain
eCenter of Comparative Medicine and Bioimaging of Catalunya, Badalona, Barcelona, Spain
REC Interv Cardiol. 2024;6:127-129
Coronary obstruction following transcatheter aortic valve replacement. Risk evaluation and preventive strategies
aDepartamento de Cardiología, Institut Clinic Cardiovascular, Hospital Clinic, Barcelona, Spain
bInstitut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain
cInterventional Cardiology Service, “Montevergine” Clinic, Mercogliano, Italy
dDepartment of Advanced Biomedical Sciences – University of Naples “Federico II”, Naples, Italy
eDepartamento de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
fDivision of University Cardiology, Cardiothoracic Department, Policlinico University Hospital, Bari, Italy
gDivision of Cardiology, “SS. Annunziata” Hospital, Taranto, Italy
REC Interv Cardiol. 2024;6:117-126
Vascular access approach for structural heart procedures
aDepartamento de Cardiología, Hospital Clínic de Barcelona, Universitat de Barcelona, Barcelona, Spain
bDepartamento de Cardiología, Hospital Universitari de Bellvitge, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
cDepartamento de Cardiología, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos I, Alcorcón, Madrid, Spain
dDepartamento de Cardiología, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
eCentro de Investigación en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
fDepartamento de Cardiología, Complejo Asistencial Universitario de Salamanca (CAUSA), Salamanca, Spain
gDepartamento de Cardiología, Hospital Universitario La Paz, Madrid, Spain
REC Interv Cardiol. 2022;4:311-318
Coronary physiology at the cath lab
a Unidad de Hemodinámica, Servicio de Cardiología, Hospital Universitari i Politecnic La Fe, Valencia, Spain
b Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain
c Departamento de Cardiología Intervencionista, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Departamento de Cardiología Intervencionista, Hospital General ISSSTE Querétaro, Universidad Autónoma de Querétaro, Santiago de Querétaro, Querétaro, Mexico
e Interventional Cardiology, MedStar Washington Hospital Center, Washington DC, United States
REC Interv Cardiol. 2022;4:319-328
Calcified coronary artery disease: pathophysiology, intracoronary imaging assessment, and plaque modification techniques
Instituto Cardiovascular, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain
REC Interv Cardiol. 2022;4:216-227
Page 1 of 3
